Health
Ph.D
France
Producing new antimicrobials and enhancing the current drugs polymorphism to fight drug resistance through a new metabolic engineering framework
Affordable, new antibiotics are needed and Cyrille Pauthenier hopes to engineer yeast cells to produce them for us. To avoid toxicity, the process will take place on the outside of the cell, making collection of the new drugs easy and harmless.
TAKING DRUG DESIGN INTO CELLS AND OUT AGAIN
To add or modify information on this page, please contact us at the following address: community.research@axa.com
Cyrille
PAUTHENIER
Institution
Université d'Evry-Val-d'Essonne
Country
France
Nationality
French